Sort by
Refine Your Search
-
the Cardiovascular Research/Genetic and Molecular Epidemiology in the Department of Medicine, School of Clinical Medicine (Ref.: 532027) We now invite applications for the captioned post. Duties and Responsibilities
-
performance. Applicants should possess a Ph.D. degree, proven experience and good publication record in molecular and/or developmental biology. Experience in tissue culture and molecular biology is essential
-
communication abilities. Preference will be given to candidates with research experience in structural biology and molecular biology. In particular, we seek applicants with expertise in techniques relevant
-
one of the following programming languages: R, Perl, Python, C/C++, JAVA, etc. Experience in cancer research and/or molecular biology will be an advantage. Preference will be given to those with
-
will be given to candidates with research experience in cancer bioinformatics, cancer biology and/or cancer immunology; as well as cell/organoid culture, cellular/molecular biology, flow cytometry
-
, molecular and cell biology, and animal models. Skills in bioinformatics are advantageous. Candidates should be highly motivated and have a track record of publications in international journals. The appointee
-
the possibility of renewal subject to funding availability and satisfactory performance) Applicants should possess a doctoral degree (Ph.D.) in Stem Cell Biology, Molecular Biology, Developmental Biology, or a
-
: prior technical project management experience and excellent communication skills in English; expertise in Artificial Intelligence based Computational Fluid Dynamics frameworks; knowledge of physics
-
performance. Applicants should possess a Ph.D. degree preferably in stem cell biology, molecular biology, biomedical sciences or a related discipline. Preference will be given to those with experience in two
-
Level 3 facility is an advantage. The appointee will contribute substantially to research projects on molecular virology and immunology of emerging and re-emerging viruses (e.g. coronaviruses and